Exhaled Biomarkers in Idiopathic Pulmonary Fibrosis—A Six-Month Follow-Up Study in Patients Treated with Pirfenidone
The mechanism of action of pirfenidone in idiopathic pulmonary fibrosis (IPF) has not been fully elucidated. To offer additional insight, we evaluated the change in the cytokine profile in exhaled breath condensate (EBC) following a six-month treatment with pirfenidone in patients with IPF. EBC conc...
Main Authors: | Kaja Jaskiewicz, Katarzyna Mycroft, Marta Maskey-Warzechowska, Karolina Paralusz, Natalia Siemiez, Patrycja Nejman-Gryz, Malgorzata Barnas, Rafal Krenke, Katarzyna Gorska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/8/2523 |
Similar Items
-
Exhaled Breath Condensate in Childhood Asthma: A Review and Current Perspective
by: Michiel A. G. E. Bannier, et al.
Published: (2019-04-01) -
Determination of biomarker IL-6 in exhaled breath condensate using exhaled breath condensate collector
by: M Seifi, et al.
Published: (2017-06-01) -
Application of Pirfenidone anti-fibrosis in ophthalmology
by: Xiao Yang, et al.
Published: (2013-08-01) -
Évaluation méthodologique et clinique des marqueurs de l’atteinte pulmonaire dans l’air exhalé : comparaison de sujets présentant une pathologie respiratoire chronique et sujets témoins
by: Kornobis-Chérot, Nathalie
Published: (2012) -
Exhaled Breath Analysis in Diagnosis of Malignant Pleural Mesothelioma: Systematic Review
by: Zehra Nur Töreyin, et al.
Published: (2020-02-01)